56 results on '"Sellers, Stephanie"'
Search Results
2. TCT-396 Calcification Patterns in TAVR Explants: Informing Durability and Implications for Reintervention.
- Author
-
Sellers, Stephanie, Meier, David, Nigade, Anish Sanjay, Glenna, Cole, Tregobov, Noah, Lai, Althea, Gill, Hacina, Kim, Woong, Pirelli, Luigi, Wood, David, Webb, John, Puehler, Thomas, Tang, Gilbert, Fukuhara, Shinichi, and Sathananthan, Janarthanan
- Subjects
- *
CALCIFICATION , *DURABILITY - Published
- 2023
- Full Text
- View/download PDF
3. Direct Endothelial Nitric Oxide Synthase Activation Provides Atheroprotection in Diabetes-Accelerated Atherosclerosis.
- Author
-
Sharma, Arpeeta, Sellers, Stephanie, Stefanovic, Nada, Leung, Cleo, Sih Min Tan, Huet, Olivier, Granville, David J., Cooper, Mark E., de Haan, Judy B., Bernatchez, Pascal, and Tan, Sih Min
- Subjects
- *
ENDOTHELIUM diseases , *NITRIC-oxide synthases , *ATHEROSCLEROSIS , *DIABETES , *CAVEOLINS , *OXIDATIVE stress , *PEPTIDES , *LEUCOCYTES , *ANIMAL experimentation , *CARRIER proteins , *CELLULAR signal transduction , *DIABETIC angiopathies , *ENDOTHELIUM , *EPITHELIAL cells , *MICE , *OXIDOREDUCTASES , *RESEARCH funding - Abstract
Patients with diabetes have an increased risk of developing atherosclerosis. Endothelial dysfunction, characterized by the lowered bioavailability of endothelial NO synthase (eNOS)-derived NO, is a critical inducer of atherosclerosis. However, the protective aspect of eNOS in diabetes-associated atherosclerosis remains controversial, a likely consequence of its capacity to release both protective NO or deleterious oxygen radicals in normal and disease settings, respectively. Harnessing the atheroprotective activity of eNOS in diabetic settings remains elusive, in part due to the lack of endogenous eNOS-specific NO release activators. We have recently shown in vitro that eNOS-derived NO release can be increased by blocking its binding to Caveolin-1, the main coat protein of caveolae, using a highly specific peptide, CavNOxin. However, whether targeting eNOS using this peptide can attenuate diabetes-associated atherosclerosis is unknown. In this study, we show that CavNOxin can attenuate atherosclerotic burden by ∼84% in vivo. In contrast, mice lacking eNOS show resistance to CavNOxin treatment, indicating eNOS specificity. Mechanistically, CavNOxin lowered oxidative stress markers, inhibited the expression of proatherogenic mediators, and blocked leukocyte-endothelial interactions. These data are the first to show that endogenous eNOS activation can provide atheroprotection in diabetes and suggest that CavNOxin is a viable strategy for the development of antiatherosclerotic compounds. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
4. Balloon-Expandable Valve for Treatment of Evolut Valve Failure: Implications on Neo-Skirt Height and Leaflet Overhang.
- Author
-
Akodad, Mariama, Sellers, Stephanie, Landes, Uri, Meier, David, Tang, Gilbert H.L., Gada, Hemal, Rogers, Toby, Caskey, Michael, Rutkin, Bruce, Puri, Rishi, Rovin, Joshua, Leipsic, Jonathon, Sondergaard, Lars, Grubb, Kendra J., Gleason, Patrick, Garde, Kshitija, Tadros, Hatem, Teodoru, Sebastian, Wood, David A., and Webb, John G.
- Subjects
- *
VALVES , *PAMPHLETS , *THERAPEUTICS - Published
- 2022
- Full Text
- View/download PDF
5. No Impact of Lentiviral Transduction on Hematopoietic Stem/Progenitor Cell Telomere Length or Gene Expression in the Rhesus Macaque Model.
- Author
-
Sellers, Stephanie E, Dumitriu, Bogdan, Morgan, Mary J, Hughes, William M., Wu, Colin O, Raghavarchari, Nalini, Yang, Yanqin, Uchida, Naoya, Tisdale, John F, An, Dong S, Chen, Irvin S, Hematti, Peiman, Donahue, Robert E, LaRochelle, Andre, Young, Neal S, Calado, Rodrigo T, and Dunbar, Cynthia E
- Subjects
- *
GENE expression , *PROGENITOR cells , *LENTIVIRUSES , *CARCINOGENESIS , *BLOOD cells , *PRINCIPAL components analysis - Abstract
The occurrence of clonal perturbations and leukemia in patients transplanted with gamma-retroviral (RV) vector-transduced autologous hematopoietic stem and progenitor cells (HSPCs) has stimulated extensive investigation, demonstrating that proviral insertions may perturb adjacent proto-oncogene expression. Although enhancer-deleted lentiviruses are less likely to result in insertional oncogenesis, there is evidence that they may perturb transcript splicing, and one patient with a benign clonal expansion of lentivirally transduced HPSC has been reported. The rhesus macaque model provides an opportunity for informative long-term analysis to ask whether transduction impacts on long-term HSPC properties. We used two techniques to examine whether lentivirally transduced HSPCs from eight rhesus macaques transplanted 1-13.5 years previously are perturbed at a population level, comparing telomere length as a measure of replicative history and gene expression profile of vector positive versus vector negative cells. There were no differences in telomere lengths between sorted GFP+ and GFP− blood cells, suggesting that lentiviral (LV) transduction did not globally disrupt replicative patterns. Bone marrow GFP+ and GFP− CD34+ cells showed no differences in gene expression using unsupervised and principal component analysis. These studies did not uncover any global long-term perturbation of proliferation, differentiation, or other important functional parameters of transduced HSPCs in the rhesus macaque model. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
6. TCT-164 Leaflet and Neoskirt Height in Transcatheter Heart Valves: Implications for Repeated Procedures and Coronary Access.
- Author
-
Akodad, Mariama, Sellers, Stephanie, Gulsin, Gaurav, Tzimas, Georgios, Landes, Uri, Chatfield, Andrew, Chuang, Anthony, Meier, David, Leipsic, Jonathon, Blanke, Philipp, Ye, Jian, Cheung, Anson, Wood, David, Khan, Jaffar, Webb, John, and Sathananthan, Janarthanan
- Subjects
- *
HEART valves , *PAMPHLETS , *MECHANICAL hearts - Published
- 2021
- Full Text
- View/download PDF
7. Nitric Oxide and TNFα Are Critical Regulators of Reversible Lymph Node Vascular Remodeling and Adaptive Immune Response.
- Author
-
Sellers, Stephanie L., Iwasaki, Akiko, and Payne, Geoffrey W.
- Subjects
- *
TUMOR necrosis factor receptors , *NITRIC oxide , *LYMPH node physiology , *IMMUNE response , *MOLECULAR biology , *HERPES simplex , *CELLULAR signal transduction , *SEXUALLY transmitted diseases - Abstract
Lymph node (LN) vascular growth, at the level of the main arteriole, was recently characterized for the first time during infection. Arteriole diameter was shown to increase for at least seven days and to occur via a CD4+ T cell dependent mechanism, with vascular expansion playing a critical role in regulating induction of adaptive immune response. Here, using intravital microscopy of the inguinal LN during herpes simplex type II (HSV-2) infection, the data provides the first studies that demonstrate arteriole expansion during infection is a reversible vascular event that occurs via eutrophic outward remodeling. Furthermore, using genetic ablation models, and pharmacological blockade, we reveal arteriole remodeling and LN hypertrophy to be dependent upon both endothelial nitric oxide synthase (eNOS) and TNFα expression. Additionally, we reveal transient changes in nitric oxide (NO) levels to be a notable feature of response to viral infection and LN vascular remodeling and provide evidence that mast cells are the critical source of TNFα required to drive arteriole remodeling. Overall, this study is the first to fully characterize LN arteriole vascular changes throughout the course of infection. It effectively reveals a novel role for NO and TNFα in LN cellularity and changes in LN vascularity, which represent key advances in understanding LN vascular physiology and adaptive immune response. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
8. Ex Vivo Expansion of Retrovirally Transduced Primate CD34+ Cells Results in Overrepresentation of Clones With MDS1/EVI1 Insertion Sites in the Myeloid Lineage After Transplantation.
- Author
-
Sellers, Stephanie, Gomes, Theotonius J., Larochelle, Andre, Lopez, Rebecca, Adler, Rima, Krouse, Allen, Donahue, Robert E., Childs, Richard W., and Dunbar, Cynthia E.
- Subjects
- *
RETROVIRUS diseases , *CELL transplantation , *HEMATOPOIETIC stem cells , *MOLECULAR genetics , *MOLECULAR cloning , *GENE expression , *GENETIC transduction , *GENE therapy - Abstract
Activation of proto-oncogenes by retroviral insertion is an important issue delaying clinical development of gene therapy. We have reported the nonrandom persistence of hematopoietic clones with vector insertions within the MDS1/EVI1 locus following transplantation of rhesus macaques. We now ask whether prolonged culture of transduced CD34+ cells before transplantation selects for clones with insertions in the MDS1/EVI11 or other proto-oncogene loci. CD34+ cells were transduced with standard retroviral vectors for 4 days and then continued in culture for an additional 6 days before transplantation. A 15% of insertions identified in granulocytes 6 months post-transplant were in MDS1/EVI11, significantly increased compared to the frequency in animals transplanted with cells immediately following transduction. MDS1/EVI1 clones became more dominant over time post-transplantation in one animal that was followed long term, accompanied by an increased overall copy number of vector-containing granulocytes, with one MDS1/EVI1 clone eventually accounting for 100% of transduced granulocytes and marrow colony-forming unit (CFU). This vector insertion increased the expression of Evi1 mRNA. There was no overrepresentation of MDS1/EVI1 insertions contributing to lymphoid lineages. Strategies involving prolonged ex vivo expansion of transduced cells may increase the risk of genotoxicity. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
9. Sex differences in cardiovascular medicine: Bilateral internal mammary artery CABG.
- Author
-
Sellers, Stephanie L., Holmes, Kenneth R., and Leipsic, Jonathon A.
- Subjects
- *
INTERNAL thoracic artery , *INTERNAL medicine , *GENDER , *CORONARY artery bypass , *PREOPERATIVE risk factors - Published
- 2019
- Full Text
- View/download PDF
10. Long-Term Clinical and Molecular Follow-up of Large Animals Receiving Retrovirally Transduced Stem and Progenitor Cells: No Progression to Clonal Hematopoiesis or Leukemia
- Author
-
Kiem, Hans-Peter, Sellers, Stephanie, Thomasson, Bobbie, Morris, Julia C., Tisdale, John F., Horn, Peter A., Hematti, Peiman, Adler, Rima, Kuramoto, Ken, Calmels, Boris, Bonifacino, Aylin, Hu, Jiong, von Kalle, Christof, Schmidt, Manfred, Sorrentino, Brian, Nienhuis, Arthur, Blau, C. Anthony, Andrews, Robert G., Donahue, Robert E., and Dunbar, Cynthia E.
- Subjects
- *
HEMATOPOIETIC stem cells , *GENETIC transformation , *LEUKEMIA , *IMMUNOLOGICAL deficiency syndromes - Abstract
There has been significant progress toward clinically relevant levels of retroviral gene transfer into hematopoietic stem cells (HSC), and the therapeutic potential of HSC-based gene transfer has been convincingly demonstrated in children with severe combined immunodeficiency syndrome (SCID). However, the subsequent development of leukemia in two children with X-linked SCID who were apparently cured after transplantation of retrovirally corrected CD34+ cells has raised concerns regarding the safety of gene therapy approaches utilizing integrating vectors. Nonhuman primates and dogs represent the best available models for gene transfer safety and efficacy and are particularly valuable for evaluation of long-term effects. We have followed 42 rhesus macaques, 23 baboons, and 17 dogs with significant levels of gene transfer for a median of 3.5 years (range 1–7) after infusion of CD34+ cells transduced with retroviral vectors expressing marker or drug-resistance genes. None developed abnormal hematopoiesis or leukemia. Integration site analysis confirmed stable, polyclonal retrovirally marked hematopoiesis, without progression toward mono- or oligoclonality over time. These results suggest that retroviral integrations using replication-incompetent vectors, at copy numbers achieved using standard protocols, are unlikely to result in leukemogenesis and that patient- or transgene-specific factors most likely contributed to the occurrence of leukemia in the X-SCID gene therapy trial. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
11. The presence of the carboxy-terminal fragment of fibronectin allows maintenance of non-human primate long-term hematopoietic repopulating cells during extended ex vivo culture and transduction
- Author
-
Sellers, Stephanie E., Tisdale, John F., Agricola, Brian A., Donahue, Robert E., and Dunbar, Cynthia E.
- Subjects
- *
HEMATOPOIESIS , *GENE therapy , *TRANSPLANTATION immunology , *CYTOKINES - Abstract
: ObjectiveEx vivo expansion of primitive hematopoietic cells remains of interest for gene therapy and transplantation. Previous studies reported loss of repopulating activity following culture of cells for more than 4–7 days in the presence of cytokines or stromal cells. In the current study, we investigated whether prolonged culture and transduction in the presence of the carboxy-terminal portion of fibronectin (FN) could maintain or expand retrovirally transduced repopulating hematopoietic stem cells (HSCs).: MethodsThe impact of culture and transduction on rhesus macaque CD34+ peripheral blood stem cells (PBSCs) was assessed in the presence of FN and stimulatory cytokines. A competitive repopulation design using up to three retroviral vectors allowed direct comparison of repopulating activity between cells transduced and cultured for 4 days vs 10 days.: ResultsIn the first animal, all cells were cultured and transduced for 10 days, with one vector used on days 0–4 and a second on days 4–10. There was stable long-term marking from both vectors, indicating that cells cycling both early and late could engraft. In three animals, we compared cells that were cryopreserved following a 4-day transduction to cells that were continued in culture for an additional 6 days. Total marking derived from the 10-day expanded cells was significantly higher than marking from the 4-day cultured cells.: ConclusionsThese results suggest that culture on FN support allows prolonged ex vivo maintenance and even expansion of transduced repopulating stem cells. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
12. The Experience of a Native American English Professor in Central Pennsylvania.
- Author
-
Sellers, Stephanie
- Subjects
- *
RACISM , *INDIGENOUS peoples of the Americas , *COLLEGE teachers , *UNIVERSITIES & colleges - Abstract
Describes the academic life of a Native American English professor at a wealthy college in Pennsylvania. Attitude of other faculty members toward the Nativeness of the professor; Goal of the professor; Racism experienced by the professor.
- Published
- 2003
- Full Text
- View/download PDF
13. TCT-436 Aldehydes: potential drivers of valve leaflet thrombosis post transcatheter aortic valve replacement?
- Author
-
Hensey, Mark, Sellers, Stephanie, Sathananthan, Janarthanan, Murdoch, Dale, Alenezi, Abdullah, Fabre, Aurelie, Murphy, Bruce, Leipsic, Jonathon, Quinn, Martin, and Webb, John
- Subjects
- *
AORTIC valve , *PROTEIN crosslinking , *HEART valves , *PAMPHLETS , *THROMBOSIS - Published
- 2018
- Full Text
- View/download PDF
14. TCT-69 Transcatheter Aortic Heart Valves: Histological Analysis Providing Insight to Leaflet Thickening and Structural Valve Degeneration.
- Author
-
Sellers, Stephanie, Turner, Christropher, Cartlidge, Tim, Sathananthan, Janarthanan, Sin, Frances, Bouchareb, Rihab, Mooney, John, Norgaard, Bjarne, Bax, Jeroen, Bernatchez, Pascal, Dweck, Marc, Granville, David, Newby, David, Lauck, Sandra, Webb, John, Payne, Geoffrey, Pibarot, Philippe, Blanke, Philipp, Seidman, Michael, and Leipsic, Jonathon
- Subjects
- *
HEART valves , *AORTIC valve , *PAMPHLETS , *FIBROSIS - Published
- 2018
- Full Text
- View/download PDF
15. Hypertrophic cardiomyopathy masquerading as sarcoidosis: cases illustrating cardiac imaging overlap relative to pathology.
- Author
-
Sellers, Stephanie L., Ellis, Jennifer, Lai, Althea, Salcudean, Hannah, Reid, Anna B., Blanke, Philipp, McManus, Bruce M., Leipsic, Jonathon A., and Seidman, Michael A.
- Subjects
- *
HYPERTROPHIC cardiomyopathy , *CARDIAC imaging , *CARDIAC magnetic resonance imaging , *HEART failure patients , *PATHOLOGY , *SARCOIDOSIS - Abstract
• Cardiac magnetic resonance imaging (MRI) is used to evaluate heart failure patients. • Features of sarcoidosis and end-stage HCM can have overlap on MRI. • Radiologists may mistake late-stage HCM as sarcoidosis due to similar MRI features. • Assessment of cardiac specimens provides correlation to prior MRI findings. • A multidisciplinary approach using both imaging and pathology aides patient diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
16. TCT-96 Tricuspid Valve-in-Valve and Bioprosthetic Surgical Tricuspid and Pulmonic Valve Degeneration: Lessons From Imaging and Histopathology.
- Author
-
Sellers, Stephanie, Cartlidge, Tim, Hensey, Mark, Turner, Christopher, Lai, Althea, Lau, Karen, Sathananthan, Janarthanan, Blanke, Philipp, Granville, David, McManus, Bruce, Webb, John, Newby, David, Dweck, Marc, and Leipsic, Jonathon
- Subjects
- *
TRICUSPID valve , *HISTOPATHOLOGY , *TRICUSPID valve surgery , *DEGENERATION (Pathology) , *HEART valves , *CONFOCAL microscopy , *TRICUSPID valve diseases - Published
- 2019
- Full Text
- View/download PDF
17. Optimization of Enzymatic and Chemical Decellularization of Native Porcine Heart Valves for the Generation of Decellularized Xenografts.
- Author
-
Saeid Nia, Monireh, Floder, Lena Maria, Seiler, Jette Anika, Puehler, Thomas, Pommert, Nina Sophie, Berndt, Rouven, Meier, David, Sellers, Stephanie L., Sathananthan, Janarthanan, Zhang, Xiling, Hasler, Mario, Gorb, Stanislav N., Warnecke, Gregor, and Lutter, Georg
- Subjects
- *
HEART valves , *XENOGRAFTS , *HEART valve diseases , *TRITON X-100 , *IMMUNE response , *TISSUE engineering - Abstract
One of the most important medical interventions for individuals with heart valvular disease is heart valve replacement, which is not without substantial challenges, particularly for pediatric patients. Due to their biological properties and biocompatibility, natural tissue-originated scaffolds derived from human or animal sources are one type of scaffold that is widely used in tissue engineering. However, they are known for their high potential for immunogenicity. Being free of cells and genetic material, decellularized xenografts, consequently, have low immunogenicity and, thus, are expected to be tolerated by the recipient's immune system. The scaffold ultrastructure and ECM composition can be affected by cell removal agents. Therefore, applying an appropriate method that preserves intact the structure of the ECM plays a critical role in the final result. So far, there has not been an effective decellularization technique that preserves the integrity of the heart valve's ultrastructure while securing the least amount of genetic material left. This study demonstrates a new protocol with untraceable cells and residual DNA, thereby maximally reducing any chance of immunogenicity. The mechanical and biochemical properties of the ECM resemble those of native heart valves. Results from this study strongly indicate that different critical factors, such as ionic detergent omission, the substitution of Triton X-100 with Tergitol, and using a lower concentration of trypsin and a higher concentration of DNase and RNase, play a significant role in maintaining intact the ultrastructure and function of the ECM. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Tricuspid Regurgitation and TAVR: Outcomes, Risk Factors and Biomarkers.
- Author
-
Puehler, Thomas, Pommert, Nina Sophie, Freitag-Wolf, Sandra, Seoudy, Hatim, Ernst, Markus, Haneya, Assad, Sathananthan, Janarthanan, Sellers, Stephanie L., Meier, David, Schöttler, Jan, Müller, Oliver J., Salehi Ravesh, Mona, Saad, Mohammed, Frank, Derk, and Lutter, Georg
- Subjects
- *
HEART valve prosthesis implantation , *BRAIN natriuretic factor , *TRICUSPID valve insufficiency ,MORTALITY risk factors - Abstract
Background. The significance of concomitant tricuspid regurgitation (TR) in the context of transcatheter aortic valve replacement (TAVR) remains unclear. This study aimed to analyze the severity of TR before and after TAVR with regard to short- and long-term survival and to analyze the influencing factors. Methods. In our retrospective analysis, TR before and after TAVR was examined and patients were classified into groups accordingly. Special attention was paid to patients with post-interventional changes in TR. Mortality after TAVR was considered the primary endpoint of the analysis and major complications according to the Valve Academic Research Consortium 3 (VARC3) were compared. Moreover, biomarkers and risk factors for worsening or improvement of TR through TAVR were analyzed. Results. Among 775 patients who underwent TAVR in our center between January 2009 and December 2019, 686 patients (89%) featured low- and 89 patients (11%) high-grade TR. High-grade pre-TAVR TR was associated with worse short- (30-day), mid- (2-year) and long-term survival up to 8 years. Even though in nearly half of the patients with high-grade TR the regurgitation improved within seven days after TAVR (n = 42/89), this did not result in a survival benefit for this subgroup. On the other hand, a worsening of low-grade TR was seen in more than 10% of the patients (n = 73/686), which was also associated with a worse prognosis. Predictors of worsening of TR after TAVR were adipositas, impaired right ventricular function and the presence of mild TR. Age, atrial fibrillation, COPD, impaired renal function and elevated cardiac biomarkers were risk factors for mortality after TAVR independent from the grade of TR. Conclusions. Not only pre-interventional, but also post-TAVR high-grade TR is associated with a worse prognosis after TAVR. TAVR can change concomitant tricuspid regurgitation, but improvement does not have any impact on short- and long-term survival. Worsening of TR after TAVR is possible and impairs the prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Producing and Testing Prototype Tissue-Engineered 3D Tri-Leaflet Valved Stents on Biodegradable Poly-ε-Caprolactone Scaffolds.
- Author
-
Lutter, Georg, Pommert, Nina Sophie, Zhang, Xiling, Seiler, Jette, Saeid Nia, Monireh, Meier, David, Sellers, Stephanie L., Gorb, Stanislav N., Hansen, Jan-Hinnerk, Seoudy, Hatim, Müller, Oliver J., Saad, Mohammed, Haneya, Assad, Frank, Derk, Puehler, Thomas, and Sathananthan, Janarthanan
- Subjects
- *
PROSTHETIC heart valves , *PULMONARY valve , *MECHANICAL hearts , *HEART valves , *NANOFIBERS , *SCANNING electron microscopy , *FLUORESCENCE microscopy - Abstract
Transcatheter pulmonary valve replacement is a minimally-invasive alternative treatment for right ventricular outflow tract dysfunction and has been rapidly evolving over the past years. Heart valve prostheses currently available still have major limitations. Therefore, one of the significant challenges for the future is the roll out of transcatheter tissue engineered pulmonary valve replacement to more patients. In the present study, biodegradable poly-ε-caprolactone (PCL) nanofiber scaffolds in the form of a 3D leaflet matrix were successfully seeded with human endothelial colony-forming cells (ECFCs), human induced pluripotent stem cell-derived MSCs (hMSCs), and porcine MSCs (pMSCs) for three weeks for the generation of 3D tissue-engineered tri-leaflet valved stent grafts. The cell adhesion, proliferation, and distribution of these 3D heart leaflets was analyzed using fluorescence microscopy and scanning electron microscopy (SEM). All cell lineages were able to increase the overgrown leaflet area within the three-week timeframe. While hMSCs showed a consistent growth rate over the course of three weeks, ECFSs showed almost no increase between days 7 and 14 until a growth spurt appeared between days 14 and 21. More than 90% of heart valve leaflets were covered with cells after the full three-week culturing cycle in nearly all leaflet areas, regardless of which cell type was used. This study shows that seeded biodegradable PCL nanofiber scaffolds incorporated in nitinol or biodegradable stents will offer a new therapeutic option in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. Transcatheter Aortic Valve Implantation by Intercostal Access: Initial Experience with a No-Touch Technique.
- Author
-
Pommert, Nina Sophie, Zhang, Xiling, Puehler, Thomas, Seoudy, Hatim, Huenges, Katharina, Schoettler, Jan, Haneya, Assad, Friedrich, Christine, Sathananthan, Janarthanan, Sellers, Stephanie L., Meier, David, Mueller, Oliver J., Saad, Mohammed, Frank, Derk, and Lutter, Georg
- Subjects
- *
HEART valve prosthesis implantation , *THORACOTOMY , *CORONARY artery bypass , *AORTIC stenosis , *AORTIC valve diseases , *PERIPHERAL vascular diseases , *PERCUTANEOUS coronary intervention - Abstract
Background: Transcatheter aortic valve implantation (TAVI) is now a well-established therapeutic option in an elderly high-risk patient cohort with aortic valve disease. Although most commonly performed via a transfemoral route, alternative approaches for TAVI are constantly being improved. Instead of the classical mini-sternotomy, it is possible to achieve a transaortic access via a right anterior mini-thoracotomy in the second intercostal space. We describe our experience with this sternum- and rib-sparing technique in comparison to the classical transaortic approach. Methods: Our retrospective study includes 173 patients who were treated in our institution between January 2017 and April 2020 with transaortic TAVI via either upper mini-sternotomy or intercostal thoracotomy. The primary endpoint was 30-day mortality, and secondary endpoints were defined as major postoperative complications that included admission to the intensive care unit and overall hospital stay, according to the Valve Academic Research Consortium 3. Results: Eighty-two patients were treated with TAo-TAVI by upper mini-sternotomy, while 91 patients received the intercostal approach. Both groups were comparable in age (mean age: 82 years) and in the proportion of female patients. The intercostal group had a higher rate of peripheral artery disease (41% vs. 22%, p = 0.008) and coronary artery disease (71% vs. 40%, p < 0.001) with a history of percutaneous coronary intervention or coronary artery bypass grafting, resulting in significantly higher preinterventional risk evaluation (EuroScore II 8% in the intercostal vs. 4% in the TAo group, p = 0.005). Successful device implantation and a reduction of the transvalvular gradient were achieved in all cases with a significantly lower rate of trace to mild paravalvular leakage in the intercostal group (12% vs. 33%, p < 0.001). The intercostal group required significantly fewer blood transfusions (0 vs. 2 units, p = 0.001) and tended to require less reoperation (7% vs. 15%, p = 0.084). Hospital stays (9 vs. 12 d, p = 0.011) were also shorter in the intercostal group. Short- and long-term survival in the follow-up showed comparable results between the two approaches (30-day, 6-month- and 2-year mortality: 7%, 23% and 36% in the intercostal vs. 9%, 26% and 33% in the TAo group) with acute kidney injury (AKI) and reintubation being independent risk factors for mortality. Conclusions: Transaortic TAVI via an intercostal access offers a safe and effective treatment of aortic valve stenosis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
21. Confluences and Crossbloods on Turtle Island.
- Author
-
Sellers, Stephanie A.
- Subjects
- *
WOODLAND peoples (North American peoples) , *NATIVE American ethnic identity , *NATIVE American history - Published
- 2017
22. Detection and Prediction of Bioprosthetic Aortic Valve Degeneration.
- Author
-
Cartlidge, Timothy R.G., Doris, Mhairi K., Sellers, Stephanie L., Pawade, Tania A., White, Audrey C., Pessotto, Renzo, Kwiecinski, Jacek, Fletcher, Alison, Alcaide, Carlos, Lucatelli, Christophe, Densem, Cameron, Rudd, James H.F., van Beek, Edwin J.R., Tavares, Adriana, Virmani, Renu, Berman, Daniel, Leipsic, Jonathon A., Newby, David E., and Dweck, Marc R.
- Subjects
- *
AORTIC valve - Abstract
Background: Bioprosthetic aortic valve degeneration is increasingly common, often unheralded, and can have catastrophic consequences.Objectives: The authors sought to assess whether 18F-fluoride positron emission tomography (PET)-computed tomography (CT) can detect bioprosthetic aortic valve degeneration and predict valve dysfunction.Methods: Explanted degenerate bioprosthetic valves were examined ex vivo. Patients with bioprosthetic aortic valves were recruited into 2 cohorts with and without prosthetic valve dysfunction and underwent in vivo contrast-enhanced CT angiography, 18F-fluoride PET, and serial echocardiography during 2 years of follow-up.Results: All ex vivo, degenerate bioprosthetic valves displayed 18F-fluoride PET uptake that colocalized with tissue degeneration on histology. In 71 patients without known bioprosthesis dysfunction, 14 had abnormal leaflet pathology on CT, and 24 demonstrated 18F-fluoride PET uptake (target-to-background ratio 1.55 [interquartile range (IQR): 1.44 to 1.88]). Patients with increased 18F-fluoride uptake exhibited more rapid deterioration in valve function compared with those without (annualized change in peak transvalvular velocity 0.30 [IQR: 0.13 to 0.61] vs. 0.01 [IQR: -0.05 to 0.16] ms-1/year; p < 0.001). Indeed 18F-fluoride uptake correlated with deterioration in all the conventional echocardiographic measures of valve function assessed (e.g., change in peak velocity, r = 0.72; p < 0.001). Each of the 10 patients who developed new overt bioprosthesis dysfunction during follow-up had evidence of 18F-fluoride uptake at baseline (target-to-background ratio 1.89 [IQR: 1.46 to 2.59]). On multivariable analysis, 18F-fluoride uptake was the only independent predictor of future bioprosthetic dysfunction.Conclusions: 18F-fluoride PET-CT identifies subclinical bioprosthetic valve degeneration, providing powerful prediction of subsequent valvular dysfunction and highlighting patients at risk of valve failure. This technique holds major promise in the diagnosis of valvular degeneration and the surveillance of patients with bioprosthetic valves. (18F-Fluoride Assessment of Aortic Bioprosthesis Durability and Outcome [18F-FAABULOUS]; NCT02304276). [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
23. Long-Distance Gifts: For Paula Gunn Allen.
- Author
-
Sellers, Stephanie A.
- Subjects
- LONG-Distance Gifts: For Paula Gunn Allen (Poem), SELLERS, Stephanie A.
- Abstract
The article presents the poem "Long-Distance Gifts: For Paula Gunn Allen," by Stephanie A. Sellers. First line: Look into the palms of these hands; Last line: I tell jokes, then sit on the porch with my drum and sing.
- Published
- 2008
24. Characterizing and treating pulmonary pathology in Marfan syndrome (847.2).
- Author
-
Sellers, Stephanie, Chan, Rayleigh, Hirota, Jeremy, Mielnik, Michael, Hogg, James, and Bernatchez, Pascal
- Published
- 2014
- Full Text
- View/download PDF
25. Multi-species meta-analysis identifies transcriptional signatures associated with cardiac endothelial responses in the ischaemic heart.
- Author
-
Li, Ziwen, Solomonidis, Emmanouil G, Berkeley, Bronwyn, Tang, Michelle Nga Huen, Stewart, Katherine Ross, Perez-Vicencio, Daniel, McCracken, Ian R, Spiroski, Ana-Mishel, Gray, Gillian A, Barton, Anna K, Sellers, Stephanie L, Riley, Paul R, Baker, Andrew H, and Brittan, Mairi
- Subjects
- *
VASCULAR endothelial cells , *ENDOTHELIAL cells , *HEART , *REGULATOR genes , *MYOCARDIAL infarction - Abstract
Aim Myocardial infarction remains the leading cause of heart failure. The adult human heart lacks the capacity to undergo endogenous regeneration. New blood vessel growth is integral to regenerative medicine necessitating a comprehensive understanding of the pathways that regulate vascular regeneration. We sought to define the transcriptomic dynamics of coronary endothelial cells following ischaemic injuries in the developing and adult mouse and human heart and to identify new mechanistic insights and targets for cardiovascular regeneration. Methods and results We carried out a comprehensive meta-analysis of integrated single-cell RNA-sequencing data of coronary vascular endothelial cells from the developing and adult mouse and human heart spanning healthy and acute and chronic ischaemic cardiac disease. We identified species-conserved gene regulatory pathways aligned to endogenous neovascularization. We annotated injury-associated temporal shifts of the endothelial transcriptome and validated four genes: VEGF-C, KLF4, EGR1, and ZFP36. Moreover, we showed that ZFP36 regulates human coronary endothelial cell proliferation and defined that VEGF-C administration in vivo enhances clonal expansion of the cardiac vasculature post-myocardial infarction. Finally, we constructed a coronary endothelial cell meta-atlas, CrescENDO, to empower future in-depth research to target pathways associated with coronary neovascularization. Conclusion We present a high-resolution single-cell meta-atlas of healthy and injured coronary endothelial cells in the mouse and human heart, revealing a suite of novel targets with great potential to promote vascular regeneration, and providing a rich resource for therapeutic development. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
26. Transcatheter Mitral Valve Repair or Replacement: Competitive or Complementary?
- Author
-
Xiling, Zhang, Puehler, Thomas, Sondergaard, Lars, Frank, Derk, Seoudy, Hatim, Mohammad, Baland, Müller, Oliver J., Sellers, Stephanie, Meier, David, Sathananthan, Janarthanan, and Lutter, Georg
- Subjects
- *
MITRAL valve , *MITRAL valve insufficiency , *CLINICAL trials - Abstract
Over the last two decades, transcatheter devices have been developed to repair or replace diseased mitral valves (MV). Transcatheter mitral valve repair (TMVr) devices have been proven to be efficient and safe, but many anatomical structures are not compatible with these technologies. The most significant advantage of transcatheter mitral valve replacement (TMVR) over transcatheter repair is the greater and more reliable reduction in mitral regurgitation. However, there are also potential disadvantages. This review introduces the newest TMVr and TMVR devices and presents clinical trial data to identify current challenges and directions for future research. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
27. Late Balloon Valvuloplasty for Transcatheter Heart Valve Dysfunction.
- Author
-
Akodad, Mariama, Blanke, Philipp, Chuang, Ming-Yu A., Duchscherer, Jade, Sellers, Stephanie L., Chatfield, Andrew G., Gulsin, Gaurav G., Lauck, Sandra, Leipsic, Jonathon A., Meier, David, Moss, Rob R., Cheung, Anson, Sathananthan, Janarthanan, Wood, David A., Ye, Jian, and Webb, John G.
- Subjects
- *
PERCUTANEOUS balloon valvuloplasty , *HEART valves , *HEART valve prosthesis implantation , *AORTIC stenosis , *TREATMENT effectiveness , *PROSTHETIC heart valves , *CATHETERIZATION , *PROSTHESIS design & construction ,AORTIC valve surgery - Abstract
Background: Transcatheter heart valve (THV) dysfunction with an elevated gradient or paravalvular leak (PVL) may be documented late after THV implantation. Medical management, paravalvular plugs, redo THV replacement, or surgical valve replacement may be considered. However, late balloon dilatation is rarely utilized because of concerns about safety or lack of efficacy.Objectives: We aimed to evaluate the safety and efficacy of late dilatation in the management of THV dysfunction.Methods: All patients who underwent late dilatation for symptomatic THV dysfunction at 2 institutions between 2016 and 2021 were identified. Baseline, procedural characteristics, and clinical and echocardiographic outcomes were documented. THV frame expansion was assessed by multislice computed tomography before and after late dilatation.Results: Late dilatation was performed in 30 patients a median of 4.6 months (IQR: 2.3-11.0 months) after THV implantation in the aortic (n = 25; 83.3%), mitral (n = 2; 6.7%), tricuspid (n = 2; 6.7%) and pulmonary (n = 1; 3.3%) position. THV underexpansion was documented at baseline, and frame expansion substantially improved after late dilatation. The mean transvalvular gradient fell in all patients. For aortic THVs specifically, mean transaortic gradient fell from 25.4 ± 13.9 mm Hg to 10.8 ± 4.1 mm Hg; P < 0.001. PVL was reduced to ≤mild in all 11 patients with a previous >mild PVL. Embolic events, stroke, annular injury, and bioprosthetic leaflet injury were not observed. Symptomatic benefit was durable at 19.6 months (IQR: 14.8-36.1 months) follow-up.Conclusions: Balloon dilatation late after THV implantation appears feasible and safe in appropriately selected patients and may result in THV frame expansion resulting in improvements in hemodynamic performance and PVL. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
28. ASSESSING THE EFFICACY OF POST-TAVR ANATOMICAL AND HEMODYNAMIC MEASUREMENTS IN PREDICTING LEAFLET THROMBOSIS USING PRE-TAVR COMPUTED TOMOGRAPHY.
- Author
-
Venkatesh, Aniket, Esmailie, Fateme, Natarajan, Thangam, Chen, Huang, Hatoum, Hoda, Yeats, Breandan Andre Butler, Lee, Beom Jun, Gulsin, Gaurav, Tregobov, Noah, Jamieson, Colin, Sellers, Stephanie, Blanke, Philipp, Leipsic, Jonathon, Sathananthan, Janarthanan, Ruile, Philipp, Neumann, Franz-Josef, Thourani, Vinod H., and Dasi, Lakshmi Prasad
- Subjects
- *
HEMODYNAMICS , *THROMBOSIS , *FORECASTING , *MEASUREMENT - Published
- 2024
- Full Text
- View/download PDF
29. CD4+ T cells support cytotoxic T lymphocyte priming by controlling lymph node input.
- Author
-
Kumamoto, Yosuke, Mattei, Lisa M., Sellers, Stephanie, Payne, Geoffrey W., and Iwasaki, Akiko
- Subjects
- *
LYMPHOCYTES , *DENDRITIC cells , *IMMUNOLOGY , *LYMPHOID tissue , *IMMUNE response - Abstract
Rapid induction of CD8+ cytotoxic T lymphocyte (CTL) responses is critical to combat acute infection with intracellular pathogens. CD4+ T cells help prime antigen-specific CTLs in secondary lymphoid organs after infection in the periphery. Although the frequency of naïve precursors is very low, the immune system is able to efficiently screen for cognate CTLs through mechanisms that are not well understood. Here we examine the role of CD4+ T cells in early phases of the immune response. We show that CD4+ T cells help optimal CTL expansion by facilitating entry of naïve polyclonal CD8+ T cells into the draining lymph node (dLN) early after infection or immunization. CD4+ T cells also facilitate input of naïve B cells into reactive LNs. Such "help" involves expansion of the arteriole feeding the dLN and enlargement of the dLN through activation of dendritic cells. In an antigen and CD40-dependent manner, CD4+ T cells activate dendritic cells to support naïve lymphocyte recruitment to the dLN. Our results reveal a previously unappreciated mode of CD4+ T-cell help, whereby they increase the input of naïve lymphocytes to the relevant LN for efficient screening of cognate CD8+ T cells. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
30. Retroviral Transduction and Engraftment Ability of Primate Hematopoietic Progenitor and Stem Cells Transduced Under Serum-Free versus Serum-Containing Conditions
- Author
-
Kluge, Kimberley A., Bonifacino, Aylin C., Sellers, Stephanie, Agricola, Brian A., Donahue, Robert E., and Dunbar, Cynthia E.
- Subjects
- *
GENETIC transduction , *RETROVIRUS genetics , *STEM cells - Abstract
The ability to efficiently transduce hematopoietic stem and progenitor cells under serum-free conditions would be desirable for safety and standardization of clinical gene therapy protocols. Using rhesus macaques, we studied the transduction efficiency and engraftment ability of CD34-enriched SCF/G-CSF mobilized progenitor cells (PBSC) transduced with standard amphotropic marking vectors under serum-free and serum-containing conditions. Supernatants were collected from producer cells 16 hours after serum-free medium or medium containing 10% fetal calf serum was added. Vector titers were approximately two- to threefold higher when producer cells were cultured in serum-containing medium. However, retroviral transduction of rhesus CFU-GM was improved using serum-free vector-containing medium. For analysis of engraftment with transduced cells, three macaques had CD34+ peripheral blood stem cells split into two fractions for transduction. One fraction was transduced using serum-free vector-containing medium, and the other fraction was transduced using standard serum-containing medium. The two fractions were re-infused simultaneously following total body irradiation. In all three animals, there was equivalent marking from both vectors for 7–9 months post-transplantation. These data are encouraging regarding the removal of serum-containing medium from clinical hematopoietic cell transduction protocols, given the lack of a detrimental effect on transduction and engraftment with transduced cells. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
31. TCT-386 Sapien 3 in Degenerated Calcified Evolut: Assessing Hydrodynamic Function and Leaflet Kinematics After Redo-TAVR.
- Author
-
Sathananthan, Janarthanan, Nigade, Anish Sanjay, Meier, David, Dorman, Kyle, Javani, Shahnaz, Lai, Althea, Gill, Hacina, Webb, John, Wood, David, Tang, Gilbert, Fukuhara, Shinichi, and Sellers, Stephanie
- Subjects
- *
KINEMATICS , *PAMPHLETS - Published
- 2023
- Full Text
- View/download PDF
32. Personalized intervention cardiology with transcatheter aortic valve replacement made possible with a non-invasive monitoring and diagnostic framework.
- Author
-
Khodaei, Seyedvahid, Henstock, Alison, Sadeghi, Reza, Sellers, Stephanie, Blanke, Philipp, Leipsic, Jonathon, Emadi, Ali, and Keshavarz-Motamed, Zahra
- Subjects
- *
HEART valve prosthesis implantation , *AORTIC stenosis , *CARDIOVASCULAR diseases , *BLOOD flow , *HEART function tests - Abstract
One of the most common acute and chronic cardiovascular disease conditions is aortic stenosis, a disease in which the aortic valve is damaged and can no longer function properly. Moreover, aortic stenosis commonly exists in combination with other conditions causing so many patients suffer from the most general and fundamentally challenging condition: complex valvular, ventricular and vascular disease (C3VD). Transcatheter aortic valve replacement (TAVR) is a new less invasive intervention and is a growing alternative for patients with aortic stenosis. Although blood flow quantification is critical for accurate and early diagnosis of C3VD in both pre and post-TAVR, proper diagnostic methods are still lacking because the fluid-dynamics methods that can be used as engines of new diagnostic tools are not well developed yet. Despite remarkable advances in medical imaging, imaging on its own is not enough to quantify the blood flow effectively. Moreover, understanding of C3VD in both pre and post-TAVR and its progression has been hindered by the absence of a proper non-invasive tool for the assessment of the cardiovascular function. To enable the development of new non-invasive diagnostic methods, we developed an innovative image-based patient-specific computational fluid dynamics framework for patients with C3VD who undergo TAVR to quantify metrics of: (1) global circulatory function; (2) global cardiac function as well as (3) local cardiac fluid dynamics. This framework is based on an innovative non-invasive Doppler-based patient-specific lumped-parameter algorithm and a 3-D strongly-coupled fluid-solid interaction. We validated the framework against clinical cardiac catheterization and Doppler echocardiographic measurements and demonstrated its diagnostic utility by providing novel analyses and interpretations of clinical data in eleven C3VD patients in pre and post-TAVR status. Our findings position this framework as a promising new non-invasive diagnostic tool that can provide blood flow metrics while posing no risk to the patient. The diagnostic information, that the framework can provide, is vitally needed to improve clinical outcomes, to assess patient risk and to plan treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
33. Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin.
- Author
-
Hubbard, Richard C., Brantly, Mark L., Sellers, Stephanie E., Mitchell, Marc E., Crystal, Ronald G., Hubbard, R C, Brantly, M L, Sellers, S E, Mitchell, M E, and Crystal, R G
- Subjects
- *
DIAGNOSTIC use of aerosols , *ALPHA 1-antitrypsin , *AEROSOLS , *ALPHA 1-antitrypsin deficiency , *ANIMAL experimentation , *CLINICAL trials , *LUNGS , *NEUTROPHILS , *PERMEABILITY , *PROTEOLYTIC enzymes , *PULMONARY alveoli , *SHEEP , *CHEMICAL inhibitors - Abstract
Study Objective: To determine if aerosolization of purified human plasma alpha 1-antitrypsin is an effective means for increasing lower respiratory anti-neutrophil-elastase defenses in alpha 1-antitrypsin deficiency.Design: Nonrandomized, before-and-after trial with a 7-day treatment period. Companion studies in animals to determine lung epithelial permeability to alpha 1-antitrypsin.Patients: Twelve patients with homozygous Z-type alpha 1-antitrypsin deficiency and mild to moderate emphysema.Interventions: Aerosol administration of human plasma alpha 1-antitrypsin, 100 mg every 12 hours for 7 days. Single, 100-mg aerosol dose to anesthetized sheep with indwelling thoracic lymph duct catheters for direct assessment of lung permeability.Measurements and Main Results: Treatment resulted in increased alpha 1-antitrypsin levels in the lung epithelial lining fluid (0.28 +/- 0.07 microM before therapy to 5.86 +/- 1.03 microM after therapy) and increased anti-neutrophil-elastase capacity (0.78 +/- 0.38 microM before therapy to 4.16 +/- 0.95 microM after therapy). Aerosolized alpha 1-antitrypsin diffused across the respiratory epithelium and entered lung interstitial lymph (in sheep) and reached the systemic circulation (in sheep and humans). No side effects were noted.Conclusion: Short-term aerosol administration of human plasma alpha 1-antitrypsin to patients with alpha 1-antitrypsin deficiency is safe and feasible, resulting in a return to normal of anti-neutrophil-elastase defenses in the lower respiratory tract. The aerosol approach, therefore, merits serious long-term evaluation as an alternative to other parenteral forms of administering therapeutic proteins. [ABSTRACT FROM AUTHOR]- Published
- 1989
- Full Text
- View/download PDF
34. Ex vivo 18F-fluoride uptake and hydroxyapatite deposition in human coronary atherosclerosis.
- Author
-
Moss, Alastair J., Sim, Alisia M., Adamson, Philip D., Seidman, Michael A., Andrews, Jack P. M., Doris, Mhairi K., Shah, Anoop S. V., BouHaidar, Ralph, Alcaide-Corral, Carlos J., Williams, Michelle C., Leipsic, Jonathon A., Dweck, Marc R., MacRae, Vicky E., Newby, David E., Tavares, Adriana A. S., and Sellers, Stephanie L.
- Subjects
- *
ACUTE coronary syndrome , *CALCIFICATIONS of the breast , *RADIOACTIVE tracers , *HYDROXYAPATITE , *OSTEOPONTIN - Abstract
Early microcalcification is a feature of coronary plaques with an increased propensity to rupture and to cause acute coronary syndromes. In this ex vivo imaging study of coronary artery specimens, the non-invasive imaging radiotracer, 18F-fluoride, was highly selective for hydroxyapatite deposition in atherosclerotic coronary plaque. Specifically, coronary 18F-fluoride uptake had a high signal to noise ratio compared with surrounding myocardium that makes it feasible to identify coronary mineralisation activity. Areas of 18F-fluoride uptake are associated with osteopontin, an inflammation-associated glycophosphoprotein that mediates tissue mineralisation, and Runt-related transcription factor 2, a nuclear protein involved in osteoblastic differentiation. These results suggest that 18F-fluoride is a non-invasive imaging biomarker of active coronary atherosclerotic mineralisation. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
35. TCT-758 Assessment of Bioprosthetic Valve Leaflet Displacement During Valve-in-Valve TAVI; an Ex-Vivo Bench Study.
- Author
-
Hensey, Mark, Sathananthan, Janarthanan, Sellers, Stephanie, Lai, Althea, Landes, Uri, Alkhodair, Abdullah, Cheung, Anson, Blanke, Philipp, Leipsic, Jonathon, Wood, David, Ye, Jian, and Webb, John
- Subjects
- *
VALVES , *PAMPHLETS , *HEART valve prosthesis implantation - Published
- 2019
- Full Text
- View/download PDF
36. Impact of sublingual nitroglycerin dosage on FFRCT assessment and coronary luminal volume-to-myocardial mass ratio.
- Author
-
Holmes, Kenneth R., Fonte, Tim A., Weir-McCall, Jonathan, Anastasius, Malcolm, Blanke, Philipp, Payne, Geoffrey W., Ellis, Jen, Murphy, Darra T., Taylor, Charles, Leipsic, Jonathon A., and Sellers, Stephanie L.
- Subjects
- *
NITROGLYCERIN , *WILCOXON signed-rank test , *HYPEREMIA , *DRUG dosage , *CORONARY vasospasm , *COMPUTED tomography , *CORONARY arteries - Abstract
Objectives: Fractional flow reserve computed tomography (FFRCT) depends upon nitroglycerin (NTG) inducing maximal hyperemia. However, the impact of NTG dosages on FFRCT analysis including coronary volume-to-mass ratio (V/M) is unknown.Methods: Eighty patients with repeat coronary CT angiograms (CCTAs) with different sublingual spray NTG doses (0.4 mg and 0.8 mg) were retrospectively analyzed with 45 patients excluded. Patient and scan demographics, post-stenosis and nadir FFRCT values, coronary volume, and coronary volume-to-mass ratio (V/M) were compared at initial CCTA (0.4 mg NTG) and follow-up CCTA (0.8 mg NTG). Differences were compared by Wilcoxon signed-rank test.Results: Thirty-five patients were included (time between CCTAs, 3.9 ± 1.6 years). Segment involvement score was 2.4 ± 3.3 and 2.8 ± 3.4 at initial and repeat CCTA (0.4 and 0.8 mg NTG), respectively (p = 0.004). There was similar image quality (4.1 ± 0.7 vs 4.1 ± 0.8; p = 0.51). Nadir FFRCT values did not differ in the left (0.4 mg, 0.80 ± 0.08 vs 0.8 mg, 0.80 ± 0.03; p = 0.66), right (0.4 mg, 0.90 ± 0.04 vs 0.8 mg, 0.90 ± 0.06; p = 0.25), or circumflex coronaries (0.4 mg, 0.87 ± 0.06 vs 0.8 mg, 0.88 ± 0.06; p = 0.34). Post-stenosis FFRCT values did not differ (p = 0.65). Coronary volume increased with 0.8 mg of NTG (2639 ± 753 mm3 vs 2844.8 ± 827 mm3; p = 0.009) but V/M ratio did not (p = 0.20).Conclusions: Use of 0.8 mg versus 0.4 mg of NTG in routine clinical CCTAs significantly increased coronary volume determined from FFRCT analysis but did not alter FFRCT or V/M. Further evaluation of repeat CCTAs in a more contemporaneous fashion using varied nitrate doses and disease severity is needed.Key Points: • Fractional flow reserve from computed tomography (FFRCT) is a noninvasive method for evaluating the coronary arteries and relies on nitroglycerin (NTG) to induce coronary vasodilation, but the impact of different NTG dosages is unknown. • Retrospective analysis evaluated use of different NTG doses on FFRCT. • Increased NTG dose increased coronary luminal volume on FFRCTanalysis, but did not change FFRCTvalues. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
37. Anatomic Considerations for Injection of the Lateral Atlanto-Axial Joint.
- Author
-
McNabney, Charis, Chavda, Anesh, Alabsi, Hatim, Sellers, Stephanie L, Murphy, Darra T, and Fenton, David
- Subjects
- *
BLOOD vessels , *COMPUTED tomography , *DIAGNOSTIC imaging , *INTRA-articular injections , *MENINGES , *PATIENT safety , *VERTEBRAL artery , *PAIN management , *ATLANTO-axial joint , *RETROSPECTIVE studies , *DESCRIPTIVE statistics - Abstract
Objective We aimed to define the potential complications of intra-articular steroid injections into the lateral C1-2 articulations and safety margins to the relevant structures. Methods A total of 488 contrast-enhanced computed tomography angiogram (CTA) "arch to vertex" studies were retrospectively reviewed for theoretical intersection of the vertebral artery or thecal sac and distance of the named structures from the anticipated/theoretical trajectory of injection into the lateral C1-C2 joint. Results Patients were 60.4±15.8 years old and 55.5% male. In total, seven vertebral arteries and 11 thecal sac theoretical intersections were found. In cases without a direct intersection, the distance from the trajectory (range) was 0.71±0.18 (0.22–1.44) cm to the vertebral artery and 0.6±0.22 (0.14–1.8) cm to the thecal sac. Conclusions Although injection of steroid into the lateral C1-C2 articulation for pain management has historically been reported to carry risk of severe complications due to close proximity and location variability of surrounding structures, our study quantifies the potential risk of such injections. Further, our analysis suggests that preprocedural imaging should be considered. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
38. Inonotus obliquus attenuates histamine-induced microvascular inflammation.
- Author
-
Javed, Sumreen, Mitchell, Kevin, Sidsworth, Danielle, Sellers, Stephanie L., Reutens-Hernandez, Jennifer, Massicotte, Hugues B., Egger, Keith N., Lee, Chow H., and Payne, Geoffrey W.
- Subjects
- *
ENDOTHELIUM , *MAST cells , *ANTIHISTAMINES , *CONNECTIVE tissue cells , *VASCULAR endothelium , *GLUTEAL muscles - Abstract
Cell-to-cell communication is a key element of microvascular blood flow control, including rapidly carrying signals through the vascular endothelium in response to local stimuli. This cell-to-cell communication is negatively impacted during inflammation through the disruption of junctional integrity. Such disruption is associated with promoting the onset of cardiovascular diseases as a result of altered microvascular blood flow regulation. Therefore, understanding the mechanisms how inflammation drives microvascular dysfunction and compounds that mitigate such inflammation and dysfunction are of great interest for development. As such we aimed to investigate extracts of mushrooms as potential novel compounds. Using intravital microscopy, the medicinal mushroom, Inonotus obliquus was observed, to attenuate histamine-induced inflammation conducted vasodilation in second-order arterioles in the gluteus maximus muscle of C57BL/6 mice. Mast cell activation by C48/80 similarly disrupted endothelial junctions and conducted vasodilation but only histamine was blocked by the histamine antagonist, pyrilamine not C48/80 suggesting the importance of mast cell activation. Data presented here supports that histamine induced inflammation is a major disruptor of junctional integrity, and highlights the important anti-inflammatory properties of Inonotus obliquus focusing future assessment of mast cells as putative target for Inonotus obliquus. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
39. Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B.
- Author
-
White, Zoe, Milad, Nadia, Tehrani, Arash Y., Chen, William Wei-Han, Donen, Graham, Sellers, Stephanie L., and Bernatchez, Pascal
- Subjects
- *
ANGIOTENSIN II , *LIMB-girdle muscular dystrophy , *ANGIOTENSIN receptors , *QUADRICEPS muscle , *MUSCLES , *DEVELOPMENTAL biology , *OCULAR hypotony , *TRICEPS - Abstract
There is no cure or beneficial management option for Limb-Girdle muscular dystrophy (MD) type 2B (LGMD2B). Losartan, a blood pressure (BP) lowering angiotensin II (AngII) receptor type 1 (ATR1) blocker (ARB) with unique anti-transforming growth factor-β (TGF-β) properties, can protect muscles in various types of MD such as Duchenne MD, suggesting a potential benefit for LGMD2B patients. Herein, we show in a mild, dysferlin-null mouse model of LGMD2B that losartan increased quadriceps muscle fibrosis (142%; P<0.0001). In a severe, atherogenic diet-fed model of LGMD2B recently described by our group, losartan further exacerbated dysferlin-null mouse muscle wasting in quadriceps and triceps brachii, two muscles typically affected by LGMD2B, by 40% and 51%, respectively (P<0.05). Lower TGF-β signalling was not observed with losartan, therefore plasma levels of atherogenic lipids known to aggravate LGMD2B severity were investigated. We report that losartan increased both plasma triglycerides and cholesterol concentrations in dysferlin-null mice. Other protective properties of losartan, such as increased nitric oxide release and BP lowering, were also reduced in the absence of dysferlin expression. Our data suggest that LGMD2B patients may show some resistance to the primary BP-lowering effects of losartan along with accelerated muscle wasting and dyslipidemia. Hence, we urge caution on the use of ARBs in this population as their ATR1 pathway may be dysfunctional. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
40. TCT-622 Native Valve and Neo-Sinus Remodeling Following Transcatheter Aortic Valve Replacement.
- Author
-
Yoon, Joshua, Gill, Hacina, Jelisejevas, Julius, Meier, David, Lai, Althea, Seidman, Michael, Payne, Geoffrey, Webb, John, Sathananthan, Janarthanan, and Sellers, Stephanie
- Subjects
- *
HEART valve prosthesis implantation - Published
- 2023
- Full Text
- View/download PDF
41. Effects of renin-angiotensin-aldosterone-system inhibitors on coronary atherosclerotic plaques: The PARADIGM registry.
- Author
-
Williams, Curtis, Han, Donghee, Takagi, Hidenobu, Fordyce, Christopher B., Sellers, Stephanie, Blanke, Philipp, Lin, Fay Y., Shaw, Leslee J., Lee, Sang-Eun, Andreini, Daniele, Al-Mallah, Mouaz H., Budoff, Matthew J., Cademartiri, Filippo, Chinnaiyan, Kavitha, Choi, Jung Hyun, Conte, Edoardo, Marques, Hugo, de Araújo Gonçalves, Pedro, Gottlieb, Ilan, and Hadamitzky, Martin
- Subjects
- *
ATHEROSCLEROTIC plaque , *ANGIOTENSIN-receptor blockers , *CORONARY angiography , *ACE inhibitors , *CORONARY artery disease , *BETA (Finance) , *MEDICAL registries - Abstract
Inhibition of Renin-Angiotensin-Aldosterone-System (RAAS) has been hypothesized to improve endothelial function and reduce plaque inflammation, however, their impact on the progression of coronary atherosclerosis is unclear. We aim to study the effects of RAAS inhibitor on plaque progression and composition assessed by serial coronary CT angiography (CCTA). We performed a prospective, multinational study consisting of a registry of patients without history of CAD, who underwent serial CCTAs. Patients using RAAS inhibitors were propensity matched to RAAS inhibitor naïve patients based on clinical and CCTA characteristics at baseline. Atherosclerotic plaques in CCTAs were quantitatively analyzed for percent atheroma volume (PAV) according to plaque composition. Interactions between RAAS inhibitor use and baseline PAV on plaque progression were assessed in the unmatched cohort using a multivariate linear regression model. Of 1248 patients from the registry, 299 RAAS inhibitor taking patients were matched to 299 RAAS inhibitor naïve patients. Over a mean interval of 3.9 years, there was no significant difference in annual progression of total PAV between RAAS inhibitor naïve vs taking patients (0.75 vs 0.79%/year, p = 0.66). With interaction testing in the unmatched cohort, however, RAAS inhibitor use was significantly associated with lower non-calcified plaque progression (Beta coefficient −0.100, adjusted p = 0.038) with higher levels of baseline PAV. The use of RAAS inhibitors over a period of nearly 4 years did not significantly impact on total atherosclerotic plaque progression or various plaque components. However, interaction testing to assess the differential effect of RAAS inhibition based on baseline PAV suggested a significant decrease in progression of non-calcified plaque in patients with a higher burden of baseline atherosclerosis, which should be considered hypothesis generating. [Display omitted] • The effect of ACE inhibitors and ARBs on coronary plaque progression is unclear. • Serial coronary CT angiograms allows plaque burden to be assessed over time. • Using propensity matching, plaque progression stratified by ACE/ARB use was performed. • Overall, ACE/ARB use had no significant effect on plaque progression or morphology. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
42. TCT-519 Timing of Bioprosthetic Valve Fracture in Transcatheter Valve-in-Valve Intervention: Impact on Valve Durability and Leaflet Integrity.
- Author
-
Meier, David, Payne, Geoffrey, Mostaço-Guidolin, Leila, Bouchareb, Rihab, Rich, Courtney, Lai, Althea, Chatfield, Andrew, Akodad, Mariama, Salcudean, Hannah, Puehler, Thomas, Pibarot, Philippe, Allen, Keith, Chhatriwalla, Adnan, Sondergaard, Lars, Wood, David, Webb, John, Leipsic, Jonathon, Sathananthan, Janarthanan, and Sellers, Stephanie
- Subjects
- *
BIOPROSTHETIC heart valves , *DURABILITY , *PAMPHLETS - Published
- 2022
- Full Text
- View/download PDF
43. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
- Author
-
Milad, Nadia, White, Zoe, Tehrani, Arash Y., Sellers, Stephanie, Rossi, Fabio M. V., and Bernatchez, Pascal
- Subjects
- *
BLOOD lipids , *DUCHENNE muscular dystrophy , *DYSTROPHIN , *CREATINE kinase , *HIGH density lipoproteins - Abstract
Background: Duchenne muscular dystrophy (DMD) is caused by loss of dystrophin expression and leads to severe ambulatory and cardiac function decline. However, the dystrophin-deficient mdx murine model of DMD only develops a very mild form of the disease. Our group and others have shown vascular abnormalities in animal models of MD, a likely consequence of the fact that blood vessels express the same dystrophin-associated glycoprotein complex (DGC) proteins as skeletal muscles. Methods: To test the blood vessel contribution to muscle damage in DMD, mdx4cv mice were given elevated lipid levels via apolipoprotein E (ApoE) gene knockout combined with normal chow or lipid-rich Western diets. Ambulatory function and heart function (via echocardiogram) were assessed at 4 and 7 months of age. After sacrifice, muscle histology and aortic staining were used to assess muscle pathology and atherosclerosis development, respectively. Plasma levels of total cholesterol, high-density lipoprotein (HDL), triglycerides, and creatine kinase (CK) were also measured. Results: Although there was an increase in left ventricular heart volume in mdx-ApoE mice compared to that in mdx mice, parameters of heart function were not affected. Compared with wild-type and ApoE-null, only mdx-ApoE KO mice showed significant ambulatory dysfunction. Despite no significant difference in plasma CK, histological analyses revealed that elevated plasma lipids in chow- and Western diet-fed mdx-ApoE mice was associated with severe exacerbation of muscle pathology compared to mdx mice: significant increase in myofiber damage and fibrofatty replacement in the gastrocnemius and triceps brachii muscles, more reminiscent of human DMD pathology. Finally, although both ApoE and mdx-ApoE groups displayed increased plasma lipids, mdx-ApoE exhibited atherosclerotic plaque deposition equal to or less than that of ApoE mice. Conclusions: Since others have shown that lipid abnormalities correlate with DMD severity, our data suggest that plasma lipids could be primary contributors to human DMD severity and that the notoriously mild phenotype of mdx mice might be attributable in part to their endogenously low plasma lipid profiles. Hence, DMD patients may benefit from lipid-lowering and vascular-targeted therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
44. DOES PATIENT PROSTHESIS MISMATCH DEFINED BY CT LVOT AREA PREDICT DOWNSTREAM CLINICAL OUTCOMES?
- Author
-
Mooney, John, Blanke, Philipp, Sellers, Stephanie, Dvir, Danny, Weissman, Neil, Kodali, Susheel, Thourani, Vinod, Jilaihawi, Hasan, Khalique, Omar, Hahn, Rebecca, Smith, Craig, Douglas, Pamela S., Webb, John, Rominder, Grover, Kueh, Shaw-Hua, Ohana, Mickael, Naoum, Chris, Pibarot, Philippe, Crowley, Aaron, and Jaber, Wael
- Subjects
- *
PROSTHETICS - Published
- 2017
- Full Text
- View/download PDF
45. Acquired somatic mutations in PNH reveal long-term maintenance of adaptive NK cells independent of HSPCs.
- Author
-
Corat, Marcus A. F., Schlums, Heinrich, Chuanfeng Wu, Theorell, Jakob, Espinoza, Diego A., Sellers, Stephanie E., Townsley, Danielle M., Young, Neal S., Bryceson, Yenan T., Dunbar, Cynthia E., and Winkler, Thomas
- Subjects
- *
KILLER cells , *LYMPHEDEMA , *GRANULOCYTE colony stimulating factor receptor , *CELL receptors , *CYTOKINE receptors , *GRANULOCYTE antigens , *HEMATOPOIETIC stem cells , *PROGENITOR cells - Abstract
Natural killer (NK) cells have long been considered short-lived effectors of innate immunity. However, recent animal models and human studies suggest that subsets of NK cells have adaptive features. We investigate clonal relationships of various NK-cell subsets, including the adaptive population, by taking advantage of naturally occurring X-linked somatic PIGA mutations in hematopoietic stem and progenitor cells (HSPCs) from patients with paroxysmal nocturnal hemoglobinuria (PNH). The affected HSPCs and their progeny lack expression of glycosylphosphatidylinositol (GPI) anchors on their cell surface, allowing quantification of PIGA-mutant (GPI-negative) HSPC-derived peripheral blood cell populations. The fraction of GPI-negative cells within the CD56dim NK cells was markedly lower than that of neutrophils and the CD56bright NK-cell compartments. This discrepancy was most prominent within the adaptive CD56dim NK-cell population lacking PLZF expression. The functional properties of these adaptive NK cells were similar in PNH patients and healthy individuals. Our findings support the existence of a long-lived, adaptive NK-cell population maintained independently from GPIpos CD56dim. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
46. TCT-405 Predictive Computational Modeling of THV Under-Expansion and Late Balloon Aortic Valvuloplasty to Treat THV Dysfunction.
- Author
-
Sivakumar, Sri Krishna, Akodad, Mariama, Blanke, Philipp, Sellers, Stephanie, Leipsic, Jonathon, Webb, John, Dasi, Lakshmi, and Sathananthan, Janarthanan
- Subjects
- *
PERCUTANEOUS balloon valvuloplasty , *PREDICTION models - Published
- 2022
- Full Text
- View/download PDF
47. Tissue Engineered Transcatheter Pulmonary Valved Stent Implantation: Current State and Future Prospect.
- Author
-
Zhang, Xiling, Puehler, Thomas, Seiler, Jette, Gorb, Stanislav N., Sathananthan, Janarthanan, Sellers, Stephanie, Haneya, Assad, Hansen, Jan-Hinnerk, Uebing, Anselm, Müller, Oliver J., Frank, Derk, and Lutter, Georg
- Subjects
- *
PULMONARY valve , *TISSUE engineering , *CONGENITAL heart disease , *SURGICAL stents , *HEART assist devices , *HEART valves - Abstract
Patients with the complex congenital heart disease (CHD) are usually associated with right ventricular outflow tract dysfunction and typically require multiple surgical interventions during their lives to relieve the right ventricular outflow tract abnormality. Transcatheter pulmonary valve replacement was used as a non-surgical, less invasive alternative treatment for right ventricular outflow tract dysfunction and has been rapidly developing over the past years. Despite the current favorable results of transcatheter pulmonary valve replacement, many patients eligible for pulmonary valve replacement are still not candidates for transcatheter pulmonary valve replacement. Therefore, one of the significant future challenges is to expand transcatheter pulmonary valve replacement to a broader patient population. This review describes the limitations and problems of existing techniques and focuses on decellularized tissue engineering for pulmonary valve stenting. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
48. Biodegradable Poly-ε-Caprolactone Scaffolds with ECFCs and iMSCs for Tissue-Engineered Heart Valves.
- Author
-
Lutter, Georg, Puehler, Thomas, Cyganek, Lukas, Seiler, Jette, Rogler, Anita, Herberth, Tanja, Knueppel, Philipp, Gorb, Stanislav N., Sathananthan, Janarthanan, Sellers, Stephanie, Müller, Oliver J., Frank, Derk, and Haben, Irma
- Subjects
- *
PROSTHETIC heart valves , *HEART valves , *PULMONARY valve , *PLURIPOTENT stem cells , *YOUNG'S modulus , *COLONIZATION (Ecology) , *SCANNING electron microscopy - Abstract
Clinically used heart valve prostheses, despite their progress, are still associated with limitations. Biodegradable poly-ε-caprolactone (PCL) nanofiber scaffolds, as a matrix, were seeded with human endothelial colony-forming cells (ECFCs) and human induced-pluripotent stem cells-derived MSCs (iMSCs) for the generation of tissue-engineered heart valves. Cell adhesion, proliferation, and distribution, as well as the effects of coating PCL nanofibers, were analyzed by fluorescence microscopy and SEM. Mechanical properties of seeded PCL scaffolds were investigated under uniaxial loading. iPSCs were used to differentiate into iMSCs via mesoderm. The obtained iMSCs exhibited a comparable phenotype and surface marker expression to adult human MSCs and were capable of multilineage differentiation. EFCFs and MSCs showed good adhesion and distribution on PCL fibers, forming a closed cell cover. Coating of the fibers resulted in an increased cell number only at an early time point; from day 7 of colonization, there was no difference between cell numbers on coated and uncoated PCL fibers. The mechanical properties of PCL scaffolds under uniaxial loading were compared with native porcine pulmonary valve leaflets. The Young's modulus and mean elongation at Fmax of unseeded PCL scaffolds were comparable to those of native leaflets (p = ns.). Colonization of PCL scaffolds with human ECFCs or iMSCs did not alter these properties (p = ns.). However, the native heart valves exhibited a maximum tensile stress at a force of 1.2 ± 0.5 N, whereas it was lower in the unseeded PCL scaffolds (0.6 ± 0.0 N, p < 0.05). A closed cell layer on PCL tissues did not change the values of Fmax (ECFCs: 0.6 ± 0.1 N; iMSCs: 0.7 ± 0.1 N). Here, a successful two-phase protocol, based on the timed use of differentiation factors for efficient differentiation of human iPSCs into iMSCs, was developed. Furthermore, we demonstrated the successful colonization of a biodegradable PCL nanofiber matrix with human ECFCs and iMSCs suitable for the generation of tissue-engineered heart valves. A closed cell cover was already evident after 14 days for ECFCs and 21 days for MSCs. The PCL tissue did not show major mechanical differences compared to native heart valves, which was not altered by short-term surface colonization with human cells in the absence of an extracellular matrix. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
49. TCT-62 Assessment of Coronary Artery Stenoses on Computed Tomography Angiography: Reproducibility and Repeatability Level 3 Readers Compared With Artificial Intelligence-Supported Analysts.
- Author
-
Tzimas, Georgios, Gulsin, Gaurav, Takagi, Hidenobu, Blanke, Philipp, Fournier, Stephane, Muller, Olivier, Sellers, Stephanie, and Leipsic, Jonathon
- Subjects
- *
COMPUTED tomography , *CORONARY arteries , *ANGIOGRAPHY , *STENOSIS , *STATISTICAL reliability - Published
- 2021
- Full Text
- View/download PDF
50. Distinct Genomic Integration of MLV and SIV Vectors in Primate Hematopoietic Stem and Progenitor Cells.
- Author
-
Hematti, Peiman, Bum-kee Hong, Ferguson, Cole, Adler, Rima, Hanawa, Hideki, Sellers, Stephanie, Holt, Ingeborg E., Eckfeldt, Craig E., Sharma, Yugal, Schmidt, Manfred, von Kalle, Christof, Persons, Derek A., Billings, Eric M., Verfaillie, Catherine M., Nienhuis, Arthur W., Wolfsberg, Tyra G., Dunbar, Cynthia E., and Calmels, Boris
- Subjects
- *
GENOMES , *STEM cells , *MOUSE leukemia viruses , *SIMIAN viruses , *HEMATOPOIETIC stem cells , *GENETIC transformation - Abstract
Murine leukemia virus (MLV)-derived vectors are widely used for hematopoietic stem cell (HSC) gene transfer, but lentiviral vectors such as the simian immunodeficiency virus (SIV) may allow higher efficiency transfer and better expression. Recent studies in cell lines have challenged the notion that retroviruses and retroviral vectors integrate randomly into their host genome. Medical applications using these vectors are aimed at HSCs, and thus large-scale comprehensive analysis of MLV and SIV integration in long-term repopulating HSCs is crucial to help develop improved integrating vectors. We studied integration sites in HSCs of rhesus monkeys that had been transplanted 6 mo to 6 y prior with MLV- or SIV-transduced CD34+ cells. Unique MLV (491) and SIV (501) insertions were compared to a set of in silico-generated random integration sites. While MLV integrants were located predominantly around transcription start sites, SIV integrants strongly favored transcription units and gene-dense regions of the genome. These integration patterns suggest different mechanisms for integration as well as distinct safety implications for MLV versus SIV vectors. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.